Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis
出版年份 2016 全文链接
标题
Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis
作者
关键词
Cervical cancer, Meta-analysis, Cancer treatment, Chemoradiotherapy, Histology, Surgical and invasive medical procedures, Clinical trials (cancer treatment), Publication ethics
出版物
PLoS One
Volume 11, Issue 7, Pages e0158787
出版商
Public Library of Science (PLoS)
发表日期
2016-07-21
DOI
10.1371/journal.pone.0158787
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
- (2014) Angelica Nogueira-Rodrigues et al. CANCER
- Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients
- (2013) Monic Roengvoraphoj et al. CANCER TREATMENT REVIEWS
- Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy
- (2013) Daya Nand Sharma et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Significance of Human Papillomavirus (HPV) Status and Expression of Selected Markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on Outcome After (Chemo-) Radiotherapy in Patients with Squamous Cell Carcinoma of Uterine Cervix
- (2013) Milan Vosmik et al. PATHOLOGY & ONCOLOGY RESEARCH
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
- (2012) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epidermal growth factor receptor as a biomarker for cervical cancer
- (2011) T. Soonthornthum et al. ANNALS OF ONCOLOGY
- EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target
- (2011) K Iida et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer
- (2011) Cathinka Halle et al. CLINICAL CANCER RESEARCH
- Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
- (2011) John Farley et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (2011) Alessandro D. Santin et al. GYNECOLOGIC ONCOLOGY
- Clinicopathologic Implications of the Epidermal Growth Factor Receptor, Cyclooxygenase 2 Expression, and Human Papillomavirus Status in Squamous Cell Carcinoma of the Uterine Cervix in the Elderly
- (2011) Giovanna Giordano et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy
- (2010) José Pérez-Regadera et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis
- (2010) Klaus Bodner et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer
- (2010) Jasper J.H. Eijsink et al. HUMAN PATHOLOGY
- A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix
- (2010) Russell J. Schilder et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
- (2009) M. G. Noordhuis et al. CLINICAL CANCER RESEARCH
- Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
- (2009) Fernando Rivera et al. Expert Review of Anticancer Therapy
- Correlation Among Six Biologic Factors (p53, p21WAF1, MIB-1, EGFR, HER2, and Bcl-2) and Clinical Outcomes After Curative Chemoradiation Therapy in Squamous Cell Cervical Cancer
- (2008) Hideomi Yamashita et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
- Absence of epidermal growth factor receptor mutations in cervical cancer
- (2007) H. ARIAS-PULIDO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation